Lawsuit Information Center

April 1, 2026

Paraquat Lawsuit Settlement Amounts

Our lawyers handle Paraquat lawsuits in all 50 states. This page provides the latest news and updates on Paraquat lawsuits in both state and federal courts. We also give our perspective on where this litigation is heading and provide projected settlement payouts for a viable Paraquat lawsuit. Continue reading

April 1, 2026

Monsanto Roundup Lawsuit Update

by Ronald V. Miller, Jr.

In this post, our Roundup lawyers will give you:

An update on where things stand in the Roundup class action lawsuit in February 2026
The likely direction the Roundup litigation will take moving forward, and

April 1, 2026

Maryland Juvenile Detention Center Sex Abuse Lawsuits

by Ronald V. Miller, Jr.

We now know detainees at Maryland juvenile detention centers (the Hickey School, Cheltenham, and Waxter, in particular) were often subjected to sexual abuse and assault by staff and other inmates. Awful things happened in these detention centers and until now that evil has gone unpunished.

Thanks to a new law in Maryland, victims of child sexual abuse at Maryland juvenile detention schools can now bring civil lawsuits against the state and get financial compensation. This page will look at sex abuse lawsuits against juvenile facilities in Maryland.

Our Maryland sex abuse lawyers are helping victims of juvenile detention center sex abuse get the compensation they deserve.

March 31, 2026

Uber Sexual Assault Lawsuits

by Ronald V. Miller, Jr.

Uber is facing one of the largest waves of passenger sexual assault lawsuits in U.S. history. Survivors across the country allege that Uber drivers sexually assaulted them and that the company is legally responsible because it failed to screen drivers properly, ignored prior complaints, and did not implement basic safety measures.

These claims are now consolidated in In re: Uber Technologies Inc., Passenger Sexual Assault Litigation (MDL No. 3084) in the Northern District of California. As of March 2026, more than 3,700 plaintiffs in 30 states have joined the MDL, with this number expected to continue rising throughout 2026.

The first MDL trial started in January 2026, the jury came back in early February with an $8.5 million verdict. Our lawyers believe these are exceptionally strong cases. The evidence points to a pattern: repeated warnings about dangerous drivers, no action from Uber, and preventable assaults that followed. In the courtroom, that is the kind of timeline juries understand and respond to. It is also the kind of fact pattern that can lead to substantial Uber sexual assault settlement amounts.

March 31, 2026

Camp Lejeune Lawsuit News and Updates

by Ronald V. Miller, Jr.

This page provides updates on Camp Lejeune lawsuits. Our lawyers are still working to give the latest update on the litigation, even though we are no longer taking new cases. Why? Because there is little information out there, and we are staying with victims, including those we do not represent, until the end.

We have also recently reopened the comments below to answer any questions you may have or simply give you a chance to share your thoughts.

March 30, 2026

Depo Provera Lawsuit Settlements

by Ronald V. Miller, Jr.

This page is for victims considering filing a Depo-Provera lawsuit. Our lawyers provide the latest updates on these claims, explain the litigation process, and predict Depo Provera settlement amounts.

A new scientific study has provided stunning evidence that using Depo-Provera can cause brain tumors. Women who used Depo-Provera and subsequently developed a meningioma brain tumor can file a Depo-Provera lawsuit seeking financial compensation. This new evidence is leading to a wave of Depo-Provera lawsuits nationwide.

Our lawyers are speaking to over 100 women a week who used Depo-Provera and have been diagnosed with meningioma. Our law firm is committed to this litigation and handling Depo-Provera lawsuits for women who had at least two injections and were later diagnosed with a meningioma brain tumor. If you meet these criteria, we will make the process of signing up for this litigation easy for you. Contact our Depo-Provera lawyers today at 800-553-8082 or contact us online.

March 30, 2026

Bard PowerPort Lawsuit

by Ronald V. Miller, Jr.

The Bard PowerPort (“BardPort”) is a port catheter device implanted just under the skin to allow for easy attachment to a catheter for the intravenous delivery of fluids or medication.

The Bard PowerPort has inherent design and manufacturing flaws that make the device prone to fracturing and migrating out of position. This can cause severe injuries, including internal vascular damage.

Individuals who suffered injuries due to a defective Bard PowerPort device are now bringing product liability lawsuits against the manufacturer of the PowerPort implants. Our firm is currently accepting new cases from anyone who had a Bard PowerPort port catheter device implanted and was injured due to a fracture, migration, or other implant failures.

March 29, 2026

Internal Bra Mesh Lawsuit

by Ronald V. Miller, Jr.

Thousands of women who underwent internal bra breast surgery are now experiencing serious complications from the surgical mesh placed inside them, and many are pursuing legal action against the manufacturers that promoted these products for a use the FDA never approved.

Breast mesh lawsuits allege that manufacturers of products such as AlloDerm, GalaFLEX, Phasix, and AlloMax marketed their devices for breast reconstruction, augmentation, and revision surgeries even though those applications had never been adequately studied or approved by the FDA. Patients were not warned. Surgeons were not given enough information. So when complications developed, including infection, mesh failure, chronic pain, and the need for additional surgery, most women did not have the information to connect the dots from their problems to the problems with the devices.

This page explains the internal bra mesh lawsuit in plain English: what the legal claims are, who may be eligible, what complications may qualify, and what these cases may be worth.

March 27, 2026

Dupixent Lawsuit for T-Cell Lymphoma

by Ronald V. Miller, Jr.

Dupixent (dupilumab) is a biologic medication used to treat atopic dermatitis, asthma, and other inflammatory conditions. It works by targeting specific immune pathways involved in allergic inflammation. For many patients with moderate to severe eczema, Dupixent has provided relief where topical medications failed. As a result, it has become one of the most widely prescribed biologic drugs for skin and respiratory conditions.

But for a growing number of patients, the experience with Dupixent has been very different. Over the past several years, doctors and researchers have reported cases in which patients treated with Dupixent were later diagnosed with cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma that primarily affects the skin. These reports have led to increasing scrutiny of whether Dupixent can worsen, accelerate, or mask CTCL in certain patients.

Lawyers across the country are now reviewing Dupixent lawsuits on behalf of patients who developed CTCL, mycosis fungoides, or Sézary syndrome after receiving Dupixent injections.

March 24, 2026

Spinal Cord Stimulator Lawsuit

by Ronald V. Miller, Jr.

A spinal cord stimulator is an implantable medical device used to manage chronic pain, most often involving the back or spine. These systems are marketed as a way to reduce pain by interrupting nerve signals before they reach the brain. But for a growing number of patients, the device does not just fail to help. It introduces new and sometimes permanent problems, including electrical shocks, burning pain, infections, lead migration, hardware failure, and repeat surgeries to reposition or remove equipment that was supposed to improve quality of life.

This page explains spinal cord stimulator lawsuits and why they are being filed nationwide. It focuses on what patients are alleging, how these devices have failed in real-world use, and why many of these cases go beyond ordinary medical malpractice claims. The most serious lawsuits do not center on a single surgical mistake. They examine how modern spinal cord stimulators were designed, tested, and approved, and whether patients were ever adequately warned about the risks that now recur repeatedly in medical records and FDA reports.

Many people arrive here with a practical question in mind: what do spinal cord stimulator settlement amounts look like, and how does compensation get calculated when a device causes lasting harm? That question cannot be answered in isolation. Settlement amounts and payouts are driven by the full medical timeline, including the cost of repeat surgeries, explantation, permanent loss of function, and the downstream consequences when a pain-management device leaves someone worse off than before it was implanted.